ISSN2320-2882
Impact Factor9.17
UGC ParametersAligned
Low Cost₹1501 / $59
CrossRefDOI
ESTD2013
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder

Authors

Pooja Prashant Kharosekar , Dr.Sachin R.Hangargekar , Akshay Arjun Bamankar , Harshada Balwantrao salunke , Dnyaneshwar Dagadu Dongare.

Keywords

Nanoglobules, Depression, Brain targeting, Nanotechnology, Antidepressant therapy.

Abstract

Depression is a major psychiatric disorder affecting millions globally, often associated with treatment resistance and delayed therapeutic onset. Esketamine, the S-enantiomer of ketamine, has emerged as a promising rapid-acting antidepressant targeting the NMDA receptor pathway. However, its therapeutic utility is limited by poor bioavailability, rapid metabolism, and potential systemic side effects. Nanotechnology-based drug delivery systems, particularly nanoglobules, offer a novel approach for improving the delivery of lipophilic drugs like esketamine by enhancing brain targeting and bioavailability while reducing systemic exposure. This review highlights current advances in the formulation and characterization of esketamine-loaded nanoglobules, emphasizing their potential role in improving nanotherapeutic delivery for effective management of depression.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJCRT — journal style
"Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder", IJCRT - International Journal of Creative Research Thoughts (www.ijcrt.org), ISSN:2320-2882, Vol.13, Issue 11, page no.c296-c303, November 2025, Available :https://ijcrt.org/papers/IJCRT2511298.pdf
APA — 7th edition
Kharosekar, P. P., R.Hangargekar, D. S., Bamankar, A. A., salunke, H. B., & Dongare., D. D. (2025). Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder. International Journal of Creative Research Thoughts, 13(11), c296-c303. https://ijcrt.org/viewpaperforall.php?paper=IJCRT2511298
MLA — 9th edition
Kharosekar, Pooja Prashant, et al. "Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder." International Journal of Creative Research Thoughts, vol. 13, no. 11, 2025, pp. c296-c303, https://ijcrt.org/viewpaperforall.php?paper=IJCRT2511298.
Chicago — 17th, bibliography
Kharosekar, Pooja Prashant, et al. "Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder." International Journal of Creative Research Thoughts 13, no. 11 (2025): c296-c303. https://ijcrt.org/viewpaperforall.php?paper=IJCRT2511298.
Harvard — author–date
Kharosekar, P.P. et al. (2025) 'Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder', International Journal of Creative Research Thoughts, 13(11), pp. c296-c303. Available at: https://ijcrt.org/viewpaperforall.php?paper=IJCRT2511298
IEEE — numbered reference
P. P. Kharosekar, D. S. R.Hangargekar, A. A. Bamankar, H. B. salunke and D. D. Dongare., "Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder," IJCRT, vol. 13, no. 11, pp. c296-c303, Nov. 2025.
Vancouver — biomedical
Kharosekar PP, R.Hangargekar DS, Bamankar AA, salunke HB, Dongare. DD. Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder. IJCRT. 2025 Nov;13(11):c296-c303.
AMA — 11th edition
Kharosekar PP, R.Hangargekar DS, Bamankar AA, salunke HB, Dongare. DD. Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder. IJCRT. 2025;13(11):c296-c303. Accessed at https://ijcrt.org/viewpaperforall.php?paper=IJCRT2511298
BibTeX — Zotero, Mendeley, LaTeX
@article{IJCRT2511298, author = {Pooja Prashant Kharosekar and Dr.Sachin R.Hangargekar and Akshay Arjun Bamankar and Harshada Balwantrao salunke and Dnyaneshwar Dagadu Dongare.}, title = {Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder}, journal = {International Journal of Creative Research Thoughts}, volume = {13}, number = {11}, pages = {c296-c303}, year = {2025}, month = {November}, issn = {2320-2882}, url = {https://ijcrt.org/viewpaperforall.php?paper=IJCRT2511298} }
RIS — EndNote, RefWorks
TY - JOUR AU - Kharosekar, Pooja Prashant AU - R.Hangargekar, Dr.Sachin AU - Bamankar, Akshay Arjun AU - salunke, Harshada Balwantrao AU - Dongare., Dnyaneshwar Dagadu TI - Advances in Nanoglobule Formulations for the Treatment of Major Depressive Disorder T2 - International Journal of Creative Research Thoughts JA - IJCRT VL - 13 IS - 11 PY - 2025 SN - 2320-2882 UR - https://ijcrt.org/viewpaperforall.php?paper=IJCRT2511298 SP - c296-c303 ER -

Issue

Volume 13 Issue 11, November-2025
Pages : c296-c303

Article Information

Pages
c296-c303
Published
November 2025
Registration ID
IJCRT_296387
Published Paper ID
IJCRT2511298
Research Area
Pharmacy All
Author Type
Indian Author
Location
Latur. Dist.latur, maharashtra, India
Licence
CC BY 4.0 · Open Access
ISSN & Impact Factor
2320-2882 · IF 9.17
Downloads
182

Summarise this Paper with AI

Opens your assistant with a prepared prompt. AI summaries can be incomplete or wrong — read the full paper before citing it.

Share This Article

Author Services

Certificates, printed copies and official reports for this paper

Published authors can request a hard copy of their certificate or of the printed journal, and obtain the transparent peer review and plagiarism reports for this article — each issued against this paper’s registration record.

Registration ID IJCRT_296387

About Publisher

International Journal of Creative Research Thoughts Published by IJCRT Publication
2320-2882 ISSN
9.17 Impact Factor
2013 ESTD Year
Open Access
Impact Factor 9.17, calculated from Google Scholar citation data — see how it is worked out.
An international scholarly open access journal: peer-reviewed, refereed, multidisciplinary, monthly and multilingual, with Crossref DOI registration, rich metadata and a citation generator. Verified indexing & discovery records.
IJCRT is a Transparent, Peer-Reviewed, Open Access Journal (Refereed Journal). Following the discontinuation of UGC and UGC-CARE journal listing, IJCRT is aligned with UGC’s Suggested Parameters for Choosing Peer-Reviewed Journals. UGC Public Notice

Licence

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal of Creative Research Thoughts for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

About the Journal
9.17Impact Factor UGC AlignedSuggested Parameters TransparentPeer Review
Open AccessNo Paywall
CrossrefDOI Available
Monthly12 Issues / Year
Since 2013Established
2320-2882ISSN

Article Impact

30Views
27Downloads
57Total reads
Nov 2025Published
Published · 335 days ago Today · last read yesterday
57 TOTAL
Views 30Downloads 27
90%
Readers who went on to take the PDF
Abstract views30
PDF downloads27

1.4 views and 1.3 downloads per day over 21 days counted.

Counts exclude identified crawler traffic and repeat hits from the same reader within 30 minutes. Downloads reached directly through a search engine or an existing citation link are not included, so the figure is a conservative count of activity through this site. Full statistics

Discovery & Indexing

Find this paper on search engines and scholarly indexes, and check the journal’s verified records.

Find this paperSearch
  • Google ScholarExact-title search, with citing articles once indexed.Search
  • CrossrefMetadata search across all Crossref records.Search
  • Semantic ScholarAI-powered literature search.Search
  • BASEBielefeld Academic Search Engine — open-access harvester.Search
  • ResearchGateResearch network publication search.Search

“Search” opens a live search for this paper; “Verified” opens a journal record checked on the Indexing & Discovery page. Third-party services index at their own discretion, often several weeks after publication.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹1501
Publish in a UGC CARE Approved Journal | Low Cost ₹1501 Indian Author | 🌐 $59 USD International
CrossRef DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →